Leptin, obesity and cardiovascular disease

Current Opinion in Nephrology and Hypertension

Volumn 13, Issue 2, 2004, Pages 215-223

  De Gusmao Correia, Marcelo Lima ^a   Haynes, William Geoffrey ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cardiovascular disease; Cardiovascular epidemiology; Leptin; Selective leptin resistance; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN; INSULIN; LEPTIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHY; INFLAMMATION; OBESITY; OXIDATIVE STRESS; PRESSOR RESPONSE; PRIORITY JOURNAL; REVIEW; SYMPATHETIC TONE; VASCULAR DISEASE;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY DISEASES; LEPTIN; OBESITY;

EID: 1642305609     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200403000-00010     Document Type: Review

References (80)

1. Collins S, Kuhn CM, Petro AE, et al. Role of leptin in fat regulation [letter]. Nature 1996; 380:677.
2. Haynes WG, Morgan DA, Walsh SA, et al. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100:270-278.
3. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997; 46:2040-2043.
4. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31:409-414.
5. Correia ML, Morgan DA, Sivitz WI, et al. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension 2001; 37:936-942.
6. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002; 39:496-501.
7. Aizawa-Abe M, Ogawa Y, Masuzaki H, et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105:1243-1252.
8. Haynes WG, Morgan DA, Djalali A, et al. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999; 33:542-547.
9. Correia ML, Morgan DA, Mitchell JL, et al. Role of corticotrophin- releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure. Hypertension 2001; 38:384-388.
10. Hausberg M, Morgan DA, Chapleau MA, et al. Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. J Hypertens 2002; 20:1633-1641. This interesting article demonstrates the dichotomy between the sympathetic actions of leptin on the thermogenic metabolism and cardio-renal homeostasis in rats. Thermogenic and cardio-renal sympathetic central nervous system networks responding to leptin might be completely distinct.
11. Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 2002; 20:1245-1250.
12. Correia ML, Haynes WG, Rahmouni K, et al. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002; 51:439-442.
13. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002; 39:486-490.
14. Morgan DA, Rahmouni K, Mark AL, et al. Selective leptin resistance during high fat diet in mice: preservation sympathetic activation despite attenuation of metabolic responses [abstract]. Hypertension 2001; 38:34.
15. Rahmouni K, Morgan DA, Morgan GM, et al. Renal-specific preservation of sympathoexcitatory effect of leptin in diet-induced obese mice [abstract]. Hypertension 2003; 42:421.
16. Eikelis N, Schlaich M, Aggarwal A, et al. Interactions between leptin and the human sympathetic nervous system. Hypertension 2003; 41:1072-1079. This correlation study suggests that leptinemia might be associated with increased renal sympathetic outflow in humans. The best evidence available of leptin sympathetic actions in humans derives from correlation studies because leptin has been rarely administered to human subjects.
17. Paolisso G, Manzella D, Montano N, et al. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab 2000; 85:1810-1814.
18. Narkiewicz K, Kato M, Phillips BG, et al. Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 2001; 19:1089-1094.
19. Tank J, Jordan J, Diedrich A, et al. Bound leptin and sympathetic outflow in nonobese men. J Clin Endocrinol Metab 2003; 88:4955-4959.
20. Brabant G, Horn R, von zur Muhlen A, et al. Free and protein bound leptin are distinct and independently controlled factors in energy regulation. Diabetologia 2000; 43:438-442.
21. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999; 48:903-908.
22. Lembo G, Vecchione C, Fratta L, et al. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000; 49:293-297.
23. Kuo JJ, Jones OB, Hall JE. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 2001; 37:670-676.
24. Winters B, Mo Z, Brooks-Asplund E, et al. Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J Appl Physiol 2000; 89:2382-2390.
25. Vecchione C, Maffei A, Colella S, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002; 51:168-173.
26. Vecchione C, Aretini A, Maffei A, et al. Cooperation between insulin and leptin in the modulation of vascular tone. Hypertension 2003; 42:166-170. This interesting article demonstrates that insulin and leptin cooperate to increase nitric oxide release from the vascular endothelium. The cross-talk between leptin and insulin might have an important role in the metabolic syndrome.
27. Sivitz WI, Walsh SA, Morgan DA, et al. Effects of leptin on insulin sensitivity in normal rats. Endocrinology 1997; 138:3395-3401.
28. Mitchell JL, Morgan DA, Correia ML, et al. Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation? Hypertension 2001; 38:1081-1086.
29. Gardiner SM, Kemp PA, March JE, Bennett T. Regional haemodynamic effects of recombinant murine or human leptin in conscious rats. J Pharmacol 2000; 130:805-810.
30. Jalali A, Morgan DA, Sivitz WI, et al. Does leptin cause functional peripheral sympatholysis? Am J Hypertens 2001; 14:615-618.
31. Nakagawa K, Higashi Y, Sasaki S, et al. Leptin causes vasodilation in humans. Hypertens Res 2002; 25:161-165.
32. Matsuda K, Teragawa H, Fukuda Y, et al. Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens Res 2003; 26:147-152. This interesting article demonstrates the vasodilator action of high doses of leptin on human coronary arteries in vivo. Leptin-induced coronary vasodilation appears to be independent of nitric oxide release by the vascular endothelium.
33. Jackson EK, Li P. Human leptin has natriuretic activity in the rat. Am J Physiol Renal Physiol 1997; 272:F333-F338.
34. Villarreal D, Reams G, Freeman RH, Taraben A. Renal effects of leptin in normotensive, hypertensive, and obese rats. Am J Physiol Regul lntegr Comp Physiol 1998; 275:R2056-R2060.
35. Villarreal D, Reams G, Freeman RH. Effects of renal denervation on the sodium excretory actions of leptin in hypertensive rats. Kidney Int 2000; 58:989-994.
36. Kuo JJ, Jones OB, Hall JE. Chronic cardiovascular and renal actions of leptin during hyperinsulinemia. Am J Physiol Regul lntegr Comp Physiol 2003; 284:R1037-R1042. This article shows that chronic leptin administration potentiates the pressor effect of chronic hyperinsulinemia in rats.
37. Coatmellec-Taglioni G, Dausse JP, Giudicelli Y, Ribiere C. Sexual dimorphism in cafeteria diet-induced hypertension is associated with gender-related difference in renal leptin receptor down-regulation. J Pharmacol Exp Ther 2003; 305:362-367.
38. Beltowski J, Wjcicka G, Gorny D, Marciniak A. Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na+, K+-ATPase activity in the rat: impaired effect in dietary-induced obesity. Med Sci Monit 2002; 8:BR221-BR229.
39. Kim S, Whelan J, Claycombe K, et al. Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism. J Nutr 2002; 132:1135-1140.
40. Cassis LA, English VL, Bharadwaj K, Boustany CM. Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology 2004; 145:169-174. This article demonstrates that adipocyte-derived angiotensin II increases leptin release.
41. Schorr U, Blaschke K, Turan S, et al. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens 1998; 16:1475-1480.
42. Adamczak M, Kokot F, Wiecek AW. Relationship between plasma renin profile and leptinaemia in patients with essential hypertension. J Hum Hypertens 2000; 14:503-509.
43. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11:197-200.
44. Agata J, Masuda A, Takada M, et al. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10:1171-1174.
45. Matsubara M, Chiba H, Maruoka S, Katayose S. Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. J Atheroscler Thromb 2000; 7:231-237.
46. Leyva F, Godsland IF, Ghatei M, et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998; 18:928-933.
47. Ruige JB, Dekker JM, Blum WF, et al. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoom Study. Diabetes Care 1999; 22:1097-1104.
48. Barba G, Russo O, Siani A, et al. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11:160-166.
49. Shintani M, Ikegami H, Fujisawa T, et al. Leptin gene polymorphism is associated with hypertension independent of obesity. J Clin Endocrinol Metab 2002; 87:2909-2912.
50. Rosmond R, Chagnon YC, Holm G, et al. Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab 2000; 85:3126-3131.
51. Henriksen JH, Holst JJ, Moller S, et al. Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. Clin Sci (Lond) 2000; 99:527-534.
52. Mallamaci F, Cuzzola F, Tripepi G, et al. Gender-dependent differences in plasma leptin in essential hypertension. Am J Hypertens 2000; 13:914-920.
53. El-Gharbawy AH, Kotchen JM, Grim CE, et al. Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans. Am J Hypertens 2002; 15:989-993.
54. Rutkowski MP, Klanke CA, Su YR, et al. Genetic markers at the leptin (OB) locus are not significantly linked to hypertension in African Americans. Hypertension 1998; 31:1230-1234.
55. Hu FB, Chen C, Wang B, et al. Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population. Int J Obes Relat Metab Disord 2001; 25:121-125.
56. Sudi KM, Gallistl S, Weinhandl G, et al. No evidence for leptin as an independent associate of blood pressure in childhood and juvenile obesity. J Pediatr Endocrinol Metab 2000; 13:513-521.
57. Chu NF, Wang DJ, Shieh SM. Obesity, leptin and blood pressure among children in Taiwan: the Taipei Children's Heart Study. Am J Hypertens 2001; 14:135-140.
58. Makris TK, Stavroulakis GA, Krespi PG, et al. Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension. Am Heart J 1999; 138:922-925.
59. Paolisso G, Tagliamonte MR, Galderisi M, et al. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. Hypertension 1999; 34:1047-1052.
60. Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003; 93:277-279. This article demonstrates that leptin has a direct hypertrophic effect on cultured neonatal rodent myocytes. However, neonatal myocyte trophic responses to leptin may be significantly different from adult myocardial cell responses.
61. Barouch LA, Berkowitz DE, Harrison RW, et al. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003; 108:754-759. This important article demonstrates that leptin possesses anti-hypertrophic effects in the hearts of adult mice. It is suggested that impaired leptin signaling may play an important role in the pathogenesis of left ventricular hypertrophy.
62. Nickola MW, Wold LE, Colligan PB, et al. Leptin attenuates cardiac contraction in rat ventricular myocytes: role of NO. Hypertension 2000; 36:501-505.
63. Wold LE, Relling DP, Duan J, et al. Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension: role of JAK/STAT pathway. Hypertension 2002; 39:69-74.
64. Soderberg S, Ahren B, Jansson JH, et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246:409-418.
65. Soderberg S, Stegmayr B, Ahlbeck-Glader C, et al. High leptin levels are associated with stroke. Cerebrovasc Dis 2003; 15:63-69. This article reports a case-control study suggesting that leptin might be associated with stroke.
66. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104:3052-3056.
67. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001; 47:141-150.
68. Parhami F, Tintut Y, Ballard A, et al. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 2001; 88:954-960.
69. Stephenson K, Tunstead J, Tsai A, et al. Neointimal formation after endovascular arterial injury is markedly attenuated in db/db mice. Arterioscler Thromb Vasc Biol 2003; 23:2027-2033. This article shows that impaired leptin signaling in leptin-receptor-deficient db/db mice substantially reduces (by 90%) neointimal formation after endovascular experimental lesion, suggesting a role of leptin in the restenosis process.
70. Yamagishi SI, Edelstein D, Du XL, et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276:25096-25100.
71. Beltowski J, Wojcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 2003; 170:21-29. This important article shows that leptin-dependent reductions of PON1 are followed by increased oxidative stress in rats. Chronic increases in leptin-induced oxidative stress could potentially contribute to atherogenesis.
72. Maingrette F, Renier G. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes 2003; 52:2121-2128.
73. Cleland SJ, Sattar N, Petrie JR, et al. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci (Lond) 2000; 98:531-535.
74. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12:57-65.
75. Kazumi T, Kawaguchi A, Hirano T, Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 2003; 52:1113-1116.
76. Singhal A, Farooqi IS, Cole TJ, et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002; 106:1919-1924.
77. Konstantinides S, Schafer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001; 108:1533-1540.
78. Bodary PF, Westrick RJ, Wickenheiser KJ, et al. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 2002; 287:1706-1709.
79. Maruyama I, Nakata M, Yamaji K. Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis. Ann N Y Acad Sci 2000; 902:315-319.
80. Soderberg S, Olsson T, Eliasson M, et al. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 1999; 245:533-543.